FDA grants Reddy’s a Duvvada reinspection

Dr Reddy’s has had its request for a US Food and DrugAdministration (FDA) reinspection of its oncology formulations plant in Duvvada, India, granted by the US agency. As Generics bulletin went to press, eight ‘Form 483’ observations were announced.

Dr Reddy’s has had its request for a US Food and DrugAdministration (FDA) reinspection of its oncology formulations plant in Duvvada, India, granted by the US agency. As Generics bulletin went to press, eight ‘Form 483’ observations were announced.

Earlier this year, Dr Reddy’s asked the FDA to schedule an inspection as part of ongoing efforts to resolve agency...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Earnings

More from Business